Author

Saikumar Dunga

Observed names: S.K. Dunga, Sai Kumar Dunga

Institutions: Apollo Hospitals, Jawaharlal Institute of Post Graduate Medical Education and Research

Observed institutions: Apollo Hospitals, Jawaharlal Institute of Post Graduate Medical Education and Research

ORCID: 0000-0002-4440-6227

Observed ORCID: 0000-0002-4440-6227

OpenAlex ID: A5057967886

Tele-rheumatology for overcoming socioeconomic barriers to healthcare in resource constrained settings: lessons from COVID-19 pandemic

2020 · Chengappa Kavadichanda, Sanket Shah, et al. · Rheumatology · 48

Disease characteristics and clinical outcomes of adults and children with anti-MDA-5 antibody-associated myositis: a prospective observational bicentric study

2021 · Sai Kumar Dunga, Chengappa Kavadichanda, et al. · Rheumatology International · 24

Effect of skin phototype on quantitative nailfold capillaroscopy

2022 · Devender Bairwa, Chengappa G Kavadichanda, et al. · Journal of Scleroderma and Related Disorders · 10

Performance of timed function tests as outcome measures in idiopathic inflammatory myopathy—results from a single-centre cohort

2022 · Saikumar Dunga, Chengappa Kavadichanda, et al. · Rheumatology · 8

Semi-quantitative thigh magnetic resonance imaging scores in assessing disease activity and determining long-term clinical outcome in idiopathic inflammatory myopathies: a causal mediation analysis

2023 · Mamatha Gorijavolu, Devender Bairwa, et al. · Rheumatology · 5

Pathogenesis of Muscle Weakness in Inflammatory Myositis

2020 · Sai Kumar Dunga, T. G. Sundaram, et al. · Indian Journal of Rheumatology · 5

Rituximab for the treatment of calcinosis in dermatomyositis: A case series and review of the literature

2026 · Subin Philip, Anna C Das, et al. · Rheumatology

Performance of IMACS Malignancy Risk Stratification in Idiopathic Inflammatory Myopathies: A Single-centre Retrospective Cohort Study from India

2026 · Lovely Kumari, Chengappa Kavadichanda, et al. · Indian Journal of Rheumatology

P137 Cancer risk and screening effectiveness in idiopathic inflammatory myopathy: validating IMACS guidelines in a retrospective Indian cohort

2025 · Lovely Kumari, Vishnu Koneru, et al. · Rheumatology

Role of Galectin-9, CXCL-10, APRIL, TNFRII and BAFF as Biomarkers in Idiopathic Inflammatory Myopathy: A Longitudinal Cohort Study

2024 · Saikumar Dunga, Aishwarya Gopal, et al. · Indian Journal of Rheumatology

POS0392 ROLE OF SEMIQUANTITATIVE THIGH MAGNETIC RESONANCE IMAGING (tMRI) IN DETERMINING SKELETAL MUSCLE OUTCOMES AT BASELINE AND ON FOLLOW UP IN IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMs)

2022 · M. Gorijavolu, D. Bairwa, et al. · Annals of the Rheumatic Diseases

Pos0880 Two-minute Walk Test as a Simple and Objective Outcome Measure in Idiopathic Inflammatory Myositis

2021 · S.K. Dunga, C. Kavadichanda, et al. · Annals of the Rheumatic Diseases

Sat0314 Timed Function Tests Are an Alternative to Mmt8 and Fi-2 in Inflammatory Myositis - an Observational Cohort Study

2020 · S.K. Dunga, A. M B, et al. · Annals of the Rheumatic Diseases

Works count: 13

Citation count: 100

H-index: 5

I10-index: 3